idarubicin has been researched along with chitosan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gellert, P; Le, H; Schatzlein, A; Siew, A; Thiovolet, M; Uchegbu, I | 1 |
| Hirosue, M; Lehr, CM; Loretz, B; Nafee, N; Wenz, G | 1 |
2 other study(ies) available for idarubicin and chitosan
| Article | Year |
|---|---|
Enhanced oral absorption of hydrophobic and hydrophilic drugs using quaternary ammonium palmitoyl glycol chitosan nanoparticles.
Topics: Adhesiveness; Animals; Anti-Ulcer Agents; Antibiotics, Antineoplastic; Antifungal Agents; Caco-2 Cells; Chitosan; Cyclosporine; Drug Carriers; Griseofulvin; Humans; Hydrophobic and Hydrophilic Interactions; Idarubicin; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Male; Nanoparticles; Quaternary Ammonium Compounds; Ranitidine; Rats; Rats, Wistar | 2012 |
Cyclodextrin-based star polymers as a versatile platform for nanochemotherapeutics: Enhanced entrapment and uptake of idarubicin.
Topics: Antibiotics, Antineoplastic; Caco-2 Cells; Cell Survival; Cellulose; Chitosan; Cyclodextrins; Drug Carriers; Humans; Idarubicin; L-Lactate Dehydrogenase; Lung Neoplasms; Nanoparticles; Nanotechnology; Particle Size; Polyethylene Glycols; Tumor Cells, Cultured | 2015 |